nodes	percent_of_prediction	percent_of_DWPC	metapath
Drospirenone—Progesterone Congeners—Medroxyprogesterone Acetate—uterine cancer	0.305	1	CiPCiCtD
Drospirenone—Medroxyprogesterone Acetate—uterine cancer	0.132	0.534	CrCtD
Drospirenone—Progesterone—uterine cancer	0.115	0.466	CrCtD
Drospirenone—PGR—uterine cancer	0.106	1	CbGaD
Drospirenone—NR3C2—Progesterone—uterine cancer	0.036	0.248	CbGbCtD
Drospirenone—PGR—Medroxyprogesterone Acetate—uterine cancer	0.0351	0.242	CbGbCtD
Drospirenone—AR—Medroxyprogesterone Acetate—uterine cancer	0.0282	0.194	CbGbCtD
Drospirenone—PGR—Progesterone—uterine cancer	0.0232	0.16	CbGbCtD
Drospirenone—AR—Progesterone—uterine cancer	0.0187	0.129	CbGbCtD
Drospirenone—Eplerenone—Medroxyprogesterone Acetate—uterine cancer	0.011	0.0681	CrCrCtD
Drospirenone—Eplerenone—Progesterone—uterine cancer	0.00956	0.0594	CrCrCtD
Drospirenone—Spironolactone—Medroxyprogesterone Acetate—uterine cancer	0.0083	0.0516	CrCrCtD
Drospirenone—Potassium Canrenoate—Medroxyprogesterone Acetate—uterine cancer	0.0083	0.0516	CrCrCtD
Drospirenone—Formestane—Progesterone—uterine cancer	0.008	0.0497	CrCrCtD
Drospirenone—Megestrol acetate—Medroxyprogesterone Acetate—uterine cancer	0.00759	0.0472	CrCrCtD
Drospirenone—Spironolactone—Progesterone—uterine cancer	0.00723	0.0449	CrCrCtD
Drospirenone—Potassium Canrenoate—Progesterone—uterine cancer	0.00723	0.0449	CrCrCtD
Drospirenone—Medrysone—Medroxyprogesterone Acetate—uterine cancer	0.00701	0.0435	CrCrCtD
Drospirenone—Megestrol acetate—Progesterone—uterine cancer	0.00662	0.0411	CrCrCtD
Drospirenone—Flurandrenolide—Medroxyprogesterone Acetate—uterine cancer	0.00651	0.0405	CrCrCtD
Drospirenone—Medrysone—Progesterone—uterine cancer	0.00611	0.038	CrCrCtD
Drospirenone—Cortisone acetate—Medroxyprogesterone Acetate—uterine cancer	0.00591	0.0367	CrCrCtD
Drospirenone—Medroxyprogesterone Acetate—Progesterone—uterine cancer	0.00589	0.0366	CrCrCtD
Drospirenone—Norethindrone—Progesterone—uterine cancer	0.00531	0.033	CrCrCtD
Drospirenone—Cortisone acetate—Progesterone—uterine cancer	0.00515	0.032	CrCrCtD
Drospirenone—Testosterone Propionate—Medroxyprogesterone Acetate—uterine cancer	0.00513	0.0319	CrCrCtD
Drospirenone—Progesterone—Medroxyprogesterone Acetate—uterine cancer	0.00513	0.0319	CrCrCtD
Drospirenone—Methyltestosterone—Medroxyprogesterone Acetate—uterine cancer	0.005	0.0311	CrCrCtD
Drospirenone—Testolactone—Progesterone—uterine cancer	0.005	0.031	CrCrCtD
Drospirenone—Testosterone Propionate—Progesterone—uterine cancer	0.00447	0.0278	CrCrCtD
Drospirenone—Testosterone—Medroxyprogesterone Acetate—uterine cancer	0.00445	0.0277	CrCrCtD
Drospirenone—Methyltestosterone—Progesterone—uterine cancer	0.00436	0.0271	CrCrCtD
Drospirenone—Hydrocortisone—Medroxyprogesterone Acetate—uterine cancer	0.00418	0.026	CrCrCtD
Drospirenone—Testosterone—Progesterone—uterine cancer	0.00388	0.0241	CrCrCtD
Drospirenone—PTGS2—Etoposide—uterine cancer	0.00375	0.0259	CbGbCtD
Drospirenone—Hydrocortisone—Progesterone—uterine cancer	0.00365	0.0227	CrCrCtD
Drospirenone—PGR—corpus luteum—uterine cancer	0.00252	0.178	CbGeAlD
Drospirenone—Thromboembolic event—Medroxyprogesterone Acetate—uterine cancer	0.00103	0.0742	CcSEcCtD
Drospirenone—Infarction—Medroxyprogesterone Acetate—uterine cancer	0.001	0.072	CcSEcCtD
Drospirenone—AR—semen—uterine cancer	0.00094	0.0665	CbGeAlD
Drospirenone—PGR—oviduct—uterine cancer	0.000866	0.0612	CbGeAlD
Drospirenone—AR—oviduct—uterine cancer	0.00069	0.0488	CbGeAlD
Drospirenone—Embolism venous—Progesterone—uterine cancer	0.000607	0.0437	CcSEcCtD
Drospirenone—PGR—artery—uterine cancer	0.000573	0.0406	CbGeAlD
Drospirenone—Embolism venous—Medroxyprogesterone Acetate—uterine cancer	0.00055	0.0396	CcSEcCtD
Drospirenone—Embolism—Progesterone—uterine cancer	0.000477	0.0344	CcSEcCtD
Drospirenone—Thrombosis—Progesterone—uterine cancer	0.000433	0.0312	CcSEcCtD
Drospirenone—Embolism—Medroxyprogesterone Acetate—uterine cancer	0.000432	0.0311	CcSEcCtD
Drospirenone—Thrombosis—Medroxyprogesterone Acetate—uterine cancer	0.000392	0.0282	CcSEcCtD
Drospirenone—Breast pain—Progesterone—uterine cancer	0.000351	0.0253	CcSEcCtD
Drospirenone—Breast pain—Medroxyprogesterone Acetate—uterine cancer	0.000318	0.0229	CcSEcCtD
Drospirenone—Venous thromboembolism—Epirubicin—uterine cancer	0.000299	0.0215	CcSEcCtD
Drospirenone—NR3C2—myometrium—uterine cancer	0.000298	0.0211	CbGeAlD
Drospirenone—PTGS2—artery—uterine cancer	0.000286	0.0203	CbGeAlD
Drospirenone—PGR—myometrium—uterine cancer	0.000277	0.0196	CbGeAlD
Drospirenone—Venous thromboembolism—Doxorubicin—uterine cancer	0.000277	0.0199	CcSEcCtD
Drospirenone—NR3C2—uterine cervix—uterine cancer	0.000232	0.0164	CbGeAlD
Drospirenone—NR3C2—smooth muscle tissue—uterine cancer	0.000225	0.0159	CbGeAlD
Drospirenone—AR—myometrium—uterine cancer	0.000221	0.0156	CbGeAlD
Drospirenone—Affect lability—Progesterone—uterine cancer	0.000219	0.0158	CcSEcCtD
Drospirenone—Migraine—Progesterone—uterine cancer	0.000219	0.0158	CcSEcCtD
Drospirenone—PGR—epithelium—uterine cancer	0.000217	0.0154	CbGeAlD
Drospirenone—NR3C2—renal system—uterine cancer	0.000217	0.0153	CbGeAlD
Drospirenone—PGR—uterine cervix—uterine cancer	0.000216	0.0152	CbGeAlD
Drospirenone—Mood swings—Progesterone—uterine cancer	0.000211	0.0152	CcSEcCtD
Drospirenone—NR3C2—endometrium—uterine cancer	0.00021	0.0148	CbGeAlD
Drospirenone—PGR—smooth muscle tissue—uterine cancer	0.000209	0.0148	CbGeAlD
Drospirenone—Cerebrovascular accident—Medroxyprogesterone Acetate—uterine cancer	0.000206	0.0148	CcSEcCtD
Drospirenone—PGR—decidua—uterine cancer	0.000205	0.0145	CbGeAlD
Drospirenone—NR3C2—mammalian vulva—uterine cancer	0.000203	0.0144	CbGeAlD
Drospirenone—Breast disorder—Progesterone—uterine cancer	0.000201	0.0145	CcSEcCtD
Drospirenone—Affect lability—Medroxyprogesterone Acetate—uterine cancer	0.000198	0.0143	CcSEcCtD
Drospirenone—Migraine—Medroxyprogesterone Acetate—uterine cancer	0.000198	0.0143	CcSEcCtD
Drospirenone—PGR—endometrium—uterine cancer	0.000195	0.0138	CbGeAlD
Drospirenone—NR3C2—uterus—uterine cancer	0.000193	0.0137	CbGeAlD
Drospirenone—Mood swings—Medroxyprogesterone Acetate—uterine cancer	0.000191	0.0137	CcSEcCtD
Drospirenone—Breast disorder—Medroxyprogesterone Acetate—uterine cancer	0.000182	0.0131	CcSEcCtD
Drospirenone—PGR—uterus—uterine cancer	0.00018	0.0127	CbGeAlD
Drospirenone—BCHE—myometrium—uterine cancer	0.00018	0.0127	CbGeAlD
Drospirenone—Embolism venous—Epirubicin—uterine cancer	0.000174	0.0125	CcSEcCtD
Drospirenone—NR3C2—female reproductive system—uterine cancer	0.000174	0.0123	CbGeAlD
Drospirenone—AR—epithelium—uterine cancer	0.000173	0.0123	CbGeAlD
Drospirenone—AR—uterine cervix—uterine cancer	0.000172	0.0121	CbGeAlD
Drospirenone—Depression—Progesterone—uterine cancer	0.000171	0.0123	CcSEcCtD
Drospirenone—AR—smooth muscle tissue—uterine cancer	0.000167	0.0118	CbGeAlD
Drospirenone—AR—decidua—uterine cancer	0.000164	0.0116	CbGeAlD
Drospirenone—PGR—female reproductive system—uterine cancer	0.000162	0.0114	CbGeAlD
Drospirenone—Embolism venous—Doxorubicin—uterine cancer	0.000161	0.0116	CcSEcCtD
Drospirenone—AR—renal system—uterine cancer	0.000161	0.0114	CbGeAlD
Drospirenone—NR3C2—female gonad—uterine cancer	0.000158	0.0112	CbGeAlD
Drospirenone—NR3C2—vagina—uterine cancer	0.000157	0.0111	CbGeAlD
Drospirenone—AR—endometrium—uterine cancer	0.000155	0.011	CbGeAlD
Drospirenone—Depression—Medroxyprogesterone Acetate—uterine cancer	0.000155	0.0111	CcSEcCtD
Drospirenone—Haemoglobin—Progesterone—uterine cancer	0.000155	0.0111	CcSEcCtD
Drospirenone—Haemorrhage—Progesterone—uterine cancer	0.000154	0.0111	CcSEcCtD
Drospirenone—Acute coronary syndrome—Medroxyprogesterone Acetate—uterine cancer	0.000153	0.011	CcSEcCtD
Drospirenone—Myocardial infarction—Medroxyprogesterone Acetate—uterine cancer	0.000152	0.011	CcSEcCtD
Drospirenone—AR—mammalian vulva—uterine cancer	0.00015	0.0106	CbGeAlD
Drospirenone—PGR—female gonad—uterine cancer	0.000147	0.0104	CbGeAlD
Drospirenone—PGR—vagina—uterine cancer	0.000146	0.0103	CbGeAlD
Drospirenone—Erythema multiforme—Progesterone—uterine cancer	0.000145	0.0105	CcSEcCtD
Drospirenone—AR—uterus—uterine cancer	0.000143	0.0101	CbGeAlD
Drospirenone—Haemoglobin—Medroxyprogesterone Acetate—uterine cancer	0.00014	0.0101	CcSEcCtD
Drospirenone—BCHE—uterine cervix—uterine cancer	0.00014	0.00988	CbGeAlD
Drospirenone—Angiopathy—Progesterone—uterine cancer	0.00014	0.01	CcSEcCtD
Drospirenone—Haemorrhage—Medroxyprogesterone Acetate—uterine cancer	0.000139	0.01	CcSEcCtD
Drospirenone—PTGS2—myometrium—uterine cancer	0.000138	0.00979	CbGeAlD
Drospirenone—Medroxyprogesterone Acetate—AKR1C3—uterine cancer	0.000138	0.157	CrCbGaD
Drospirenone—Embolism—Epirubicin—uterine cancer	0.000137	0.00985	CcSEcCtD
Drospirenone—BCHE—smooth muscle tissue—uterine cancer	0.000136	0.00961	CbGeAlD
Drospirenone—Mental disorder—Progesterone—uterine cancer	0.000135	0.0097	CcSEcCtD
Drospirenone—Erythema multiforme—Medroxyprogesterone Acetate—uterine cancer	0.000132	0.00949	CcSEcCtD
Drospirenone—Megestrol acetate—PGR—uterine cancer	0.000131	0.15	CrCbGaD
Drospirenone—AR—female reproductive system—uterine cancer	0.000129	0.0091	CbGeAlD
Drospirenone—Embolism—Doxorubicin—uterine cancer	0.000127	0.00912	CcSEcCtD
Drospirenone—Angiopathy—Medroxyprogesterone Acetate—uterine cancer	0.000126	0.00911	CcSEcCtD
Drospirenone—BCHE—endometrium—uterine cancer	0.000126	0.00894	CbGeAlD
Drospirenone—Thrombosis—Epirubicin—uterine cancer	0.000124	0.00894	CcSEcCtD
Drospirenone—BCHE—mammalian vulva—uterine cancer	0.000122	0.00865	CbGeAlD
Drospirenone—Mental disorder—Medroxyprogesterone Acetate—uterine cancer	0.000122	0.00879	CcSEcCtD
Drospirenone—Testolactone—CYP19A1—uterine cancer	0.000121	0.138	CrCbGaD
Drospirenone—AR—female gonad—uterine cancer	0.000117	0.00828	CbGeAlD
Drospirenone—BCHE—uterus—uterine cancer	0.000116	0.00824	CbGeAlD
Drospirenone—AR—vagina—uterine cancer	0.000116	0.00823	CbGeAlD
Drospirenone—Thrombosis—Doxorubicin—uterine cancer	0.000115	0.00827	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Progesterone—uterine cancer	0.000113	0.00815	CcSEcCtD
Drospirenone—PTGS2—epithelium—uterine cancer	0.000109	0.00768	CbGeAlD
Drospirenone—PTGS2—uterine cervix—uterine cancer	0.000108	0.00761	CbGeAlD
Drospirenone—Nervous system disorder—Progesterone—uterine cancer	0.000107	0.00772	CcSEcCtD
Drospirenone—Skin disorder—Progesterone—uterine cancer	0.000106	0.00764	CcSEcCtD
Drospirenone—BCHE—female reproductive system—uterine cancer	0.000105	0.00741	CbGeAlD
Drospirenone—PTGS2—smooth muscle tissue—uterine cancer	0.000105	0.0074	CbGeAlD
Drospirenone—Erythema multiforme—Dactinomycin—uterine cancer	0.000103	0.0074	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.000103	0.00739	CcSEcCtD
Drospirenone—NR3C2—lymph node—uterine cancer	0.000102	0.00719	CbGeAlD
Drospirenone—PTGS2—renal system—uterine cancer	0.000101	0.00712	CbGeAlD
Drospirenone—Breast pain—Epirubicin—uterine cancer	0.000101	0.00725	CcSEcCtD
Drospirenone—PTGS2—endometrium—uterine cancer	9.74e-05	0.00689	CbGeAlD
Drospirenone—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	9.71e-05	0.00699	CcSEcCtD
Drospirenone—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	9.62e-05	0.00693	CcSEcCtD
Drospirenone—BCHE—vagina—uterine cancer	9.47e-05	0.0067	CbGeAlD
Drospirenone—PGR—lymph node—uterine cancer	9.45e-05	0.00668	CbGeAlD
Drospirenone—Gastrointestinal disorder—Progesterone—uterine cancer	9.44e-05	0.00679	CcSEcCtD
Drospirenone—Breast pain—Doxorubicin—uterine cancer	9.32e-05	0.00671	CcSEcCtD
Drospirenone—PTGS2—uterus—uterine cancer	8.97e-05	0.00635	CbGeAlD
Drospirenone—Acute coronary syndrome—Etoposide—uterine cancer	8.64e-05	0.00622	CcSEcCtD
Drospirenone—Myocardial infarction—Etoposide—uterine cancer	8.59e-05	0.00619	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	8.55e-05	0.00616	CcSEcCtD
Drospirenone—Spironolactone—PGR—uterine cancer	8.16e-05	0.093	CrCbGaD
Drospirenone—PTGS2—female reproductive system—uterine cancer	8.07e-05	0.00571	CbGeAlD
Drospirenone—Medroxyprogesterone Acetate—PGR—uterine cancer	7.65e-05	0.0871	CrCbGaD
Drospirenone—Norethindrone—PGR—uterine cancer	7.58e-05	0.0863	CrCbGaD
Drospirenone—AR—lymph node—uterine cancer	7.53e-05	0.00532	CbGeAlD
Drospirenone—Erythema multiforme—Etoposide—uterine cancer	7.44e-05	0.00536	CcSEcCtD
Drospirenone—PTGS2—female gonad—uterine cancer	7.34e-05	0.00519	CbGeAlD
Drospirenone—PTGS2—vagina—uterine cancer	7.29e-05	0.00516	CbGeAlD
Drospirenone—Angiopathy—Etoposide—uterine cancer	7.14e-05	0.00514	CcSEcCtD
Drospirenone—Cerebrovascular accident—Epirubicin—uterine cancer	6.51e-05	0.00469	CcSEcCtD
Drospirenone—Nausea—Progesterone—uterine cancer	6.49e-05	0.00467	CcSEcCtD
Drospirenone—Affect lability—Epirubicin—uterine cancer	6.28e-05	0.00452	CcSEcCtD
Drospirenone—Migraine—Epirubicin—uterine cancer	6.28e-05	0.00452	CcSEcCtD
Drospirenone—BCHE—lymph node—uterine cancer	6.12e-05	0.00433	CbGeAlD
Drospirenone—Mood swings—Epirubicin—uterine cancer	6.04e-05	0.00435	CcSEcCtD
Drospirenone—Cerebrovascular accident—Doxorubicin—uterine cancer	6.02e-05	0.00434	CcSEcCtD
Drospirenone—Nausea—Medroxyprogesterone Acetate—uterine cancer	5.88e-05	0.00424	CcSEcCtD
Drospirenone—Affect lability—Doxorubicin—uterine cancer	5.81e-05	0.00418	CcSEcCtD
Drospirenone—Migraine—Doxorubicin—uterine cancer	5.81e-05	0.00418	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	5.79e-05	0.00417	CcSEcCtD
Drospirenone—Breast disorder—Epirubicin—uterine cancer	5.76e-05	0.00415	CcSEcCtD
Drospirenone—Mood swings—Doxorubicin—uterine cancer	5.59e-05	0.00402	CcSEcCtD
Drospirenone—Testosterone—CYP11A1—uterine cancer	5.54e-05	0.0631	CrCbGaD
Drospirenone—Skin disorder—Etoposide—uterine cancer	5.43e-05	0.00391	CcSEcCtD
Drospirenone—Breast disorder—Doxorubicin—uterine cancer	5.33e-05	0.00384	CcSEcCtD
Drospirenone—Methyltestosterone—CYP19A1—uterine cancer	4.94e-05	0.0562	CrCbGaD
Drospirenone—Gastrointestinal disorder—Etoposide—uterine cancer	4.83e-05	0.00348	CcSEcCtD
Drospirenone—Medroxyprogesterone Acetate—ESR1—uterine cancer	4.83e-05	0.055	CrCbGaD
Drospirenone—PTGS2—lymph node—uterine cancer	4.72e-05	0.00334	CbGeAlD
Drospirenone—Nausea—Dactinomycin—uterine cancer	4.59e-05	0.0033	CcSEcCtD
Drospirenone—Haemoglobin—Epirubicin—uterine cancer	4.43e-05	0.00319	CcSEcCtD
Drospirenone—Progesterone—PGR—uterine cancer	4.42e-05	0.0503	CrCbGaD
Drospirenone—Haemorrhage—Epirubicin—uterine cancer	4.41e-05	0.00318	CcSEcCtD
Drospirenone—Erythema multiforme—Epirubicin—uterine cancer	4.17e-05	0.003	CcSEcCtD
Drospirenone—Haemoglobin—Doxorubicin—uterine cancer	4.1e-05	0.00295	CcSEcCtD
Drospirenone—Haemorrhage—Doxorubicin—uterine cancer	4.08e-05	0.00294	CcSEcCtD
Drospirenone—Angiopathy—Epirubicin—uterine cancer	4e-05	0.00288	CcSEcCtD
Drospirenone—Mental disorder—Epirubicin—uterine cancer	3.86e-05	0.00278	CcSEcCtD
Drospirenone—Erythema multiforme—Doxorubicin—uterine cancer	3.86e-05	0.00278	CcSEcCtD
Drospirenone—Angiopathy—Doxorubicin—uterine cancer	3.7e-05	0.00267	CcSEcCtD
Drospirenone—Mental disorder—Doxorubicin—uterine cancer	3.58e-05	0.00257	CcSEcCtD
Drospirenone—Nausea—Etoposide—uterine cancer	3.32e-05	0.00239	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	3.25e-05	0.00234	CcSEcCtD
Drospirenone—PGR—Validated nuclear estrogen receptor alpha network—EP300—uterine cancer	3.11e-05	0.0044	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—TSPYL2—uterine cancer	3.09e-05	0.00438	CbGpPWpGaD
Drospirenone—Nervous system disorder—Epirubicin—uterine cancer	3.07e-05	0.00221	CcSEcCtD
Drospirenone—Skin disorder—Epirubicin—uterine cancer	3.04e-05	0.00219	CcSEcCtD
Drospirenone—PGR—Signaling by ERBB4—FGFR2—uterine cancer	3.04e-05	0.00431	CbGpPWpGaD
Drospirenone—AR—Notch-mediated HES/HEY network—EP300—uterine cancer	3.03e-05	0.00429	CbGpPWpGaD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	3e-05	0.00216	CcSEcCtD
Drospirenone—AR—Integrated Breast Cancer Pathway—CYP19A1—uterine cancer	2.99e-05	0.00423	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—STK11—uterine cancer	2.99e-05	0.00423	CbGpPWpGaD
Drospirenone—PTGS2—Aryl Hydrocarbon Receptor—ESR1—uterine cancer	2.97e-05	0.00421	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	2.94e-05	0.00417	CbGpPWpGaD
Drospirenone—NR3C2—Generic Transcription Pathway—ESR2—uterine cancer	2.92e-05	0.00413	CbGpPWpGaD
Drospirenone—AR—Nongenotropic Androgen signaling—HRAS—uterine cancer	2.89e-05	0.0041	CbGpPWpGaD
Drospirenone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—uterine cancer	2.88e-05	0.00409	CbGpPWpGaD
Drospirenone—Testosterone—CYP19A1—uterine cancer	2.86e-05	0.0326	CrCbGaD
Drospirenone—Nervous system disorder—Doxorubicin—uterine cancer	2.84e-05	0.00205	CcSEcCtD
Drospirenone—Skin disorder—Doxorubicin—uterine cancer	2.82e-05	0.00203	CcSEcCtD
Drospirenone—Progesterone—ESR1—uterine cancer	2.79e-05	0.0318	CrCbGaD
Drospirenone—AR—Regulation of Androgen receptor activity—EP300—uterine cancer	2.75e-05	0.0039	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—PHF1—uterine cancer	2.74e-05	0.00388	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	2.73e-05	0.00386	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	2.71e-05	0.00384	CbGpPWpGaD
Drospirenone—Gastrointestinal disorder—Epirubicin—uterine cancer	2.71e-05	0.00195	CcSEcCtD
Drospirenone—AR—Coregulation of Androgen receptor activity—CTNNB1—uterine cancer	2.65e-05	0.00375	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—INHBA—uterine cancer	2.64e-05	0.00373	CbGpPWpGaD
Drospirenone—PGR—Signaling by ERBB4—ESR1—uterine cancer	2.6e-05	0.00369	CbGpPWpGaD
Drospirenone—AR—Nongenotropic Androgen signaling—AKT1—uterine cancer	2.55e-05	0.00362	CbGpPWpGaD
Drospirenone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—uterine cancer	2.55e-05	0.00361	CbGpPWpGaD
Drospirenone—Gastrointestinal disorder—Doxorubicin—uterine cancer	2.5e-05	0.0018	CcSEcCtD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	2.47e-05	0.00351	CbGpPWpGaD
Drospirenone—NR3C2—Generic Transcription Pathway—CDKN2B—uterine cancer	2.38e-05	0.00336	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—CHD4—uterine cancer	2.33e-05	0.0033	CbGpPWpGaD
Drospirenone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—uterine cancer	2.31e-05	0.00327	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	2.22e-05	0.00314	CbGpPWpGaD
Drospirenone—NR3C2—Generic Transcription Pathway—SMAD3—uterine cancer	2.17e-05	0.00307	CbGpPWpGaD
Drospirenone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—uterine cancer	2.13e-05	0.00302	CbGpPWpGaD
Drospirenone—AR—Gene Expression—PHF1—uterine cancer	2.09e-05	0.00296	CbGpPWpGaD
Drospirenone—PTGS2—Aryl Hydrocarbon Receptor—CDKN1B—uterine cancer	2.02e-05	0.00286	CbGpPWpGaD
Drospirenone—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—uterine cancer	2.01e-05	0.00284	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—ESR1—uterine cancer	1.99e-05	0.00283	CbGpPWpGaD
Drospirenone—PTGS2—Selenium Micronutrient Network—MTHFR—uterine cancer	1.99e-05	0.00282	CbGpPWpGaD
Drospirenone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—uterine cancer	1.98e-05	0.0028	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—STAR—uterine cancer	1.96e-05	0.00278	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	1.96e-05	0.00278	CbGpPWpGaD
Drospirenone—AR—Regulation of nuclear SMAD2/3 signaling—EP300—uterine cancer	1.96e-05	0.00278	CbGpPWpGaD
Drospirenone—AR—Androgen receptor signaling pathway—CTNNB1—uterine cancer	1.96e-05	0.00277	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—SUZ12—uterine cancer	1.95e-05	0.00276	CbGpPWpGaD
Drospirenone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—uterine cancer	1.93e-05	0.00274	CbGpPWpGaD
Drospirenone—PGR—Signaling by ERBB4—ERBB2—uterine cancer	1.91e-05	0.00271	CbGpPWpGaD
Drospirenone—AR—Androgen receptor signaling pathway—PTEN—uterine cancer	1.91e-05	0.0027	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	1.87e-05	0.00264	CbGpPWpGaD
Drospirenone—Nausea—Epirubicin—uterine cancer	1.86e-05	0.00134	CcSEcCtD
Drospirenone—AR—Androgen receptor signaling pathway—EP300—uterine cancer	1.82e-05	0.00257	CbGpPWpGaD
Drospirenone—PGR—Generic Transcription Pathway—ESR2—uterine cancer	1.78e-05	0.00252	CbGpPWpGaD
Drospirenone—AR—Gene Expression—CHD4—uterine cancer	1.77e-05	0.00251	CbGpPWpGaD
Drospirenone—PTGS2—Aryl Hydrocarbon Receptor—EP300—uterine cancer	1.77e-05	0.00251	CbGpPWpGaD
Drospirenone—PGR—Signaling by ERBB4—CDKN1B—uterine cancer	1.77e-05	0.00251	CbGpPWpGaD
Drospirenone—NR3C2—Generic Transcription Pathway—ESR1—uterine cancer	1.77e-05	0.00251	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—CDH1—uterine cancer	1.74e-05	0.00246	CbGpPWpGaD
Drospirenone—Nausea—Doxorubicin—uterine cancer	1.72e-05	0.00124	CcSEcCtD
Drospirenone—BCHE—Peptide hormone metabolism—CTNNB1—uterine cancer	1.69e-05	0.0024	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	1.69e-05	0.00239	CbGpPWpGaD
Drospirenone—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—uterine cancer	1.68e-05	0.00238	CbGpPWpGaD
Drospirenone—PTGS2—Aryl Hydrocarbon Receptor—NRAS—uterine cancer	1.66e-05	0.00235	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	1.65e-05	0.00234	CbGpPWpGaD
Drospirenone—PGR—Signaling by ERBB4—PTEN—uterine cancer	1.63e-05	0.00231	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—PGR—uterine cancer	1.6e-05	0.00226	CbGpPWpGaD
Drospirenone—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—uterine cancer	1.58e-05	0.00224	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	1.57e-05	0.00222	CbGpPWpGaD
Drospirenone—PTGS2—Selenium Micronutrient Network—CCL2—uterine cancer	1.56e-05	0.0022	CbGpPWpGaD
Drospirenone—AR—Generic Transcription Pathway—PGR—uterine cancer	1.54e-05	0.00218	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—EZH2—uterine cancer	1.52e-05	0.00215	CbGpPWpGaD
Drospirenone—AR—Gene Expression—SUZ12—uterine cancer	1.49e-05	0.00211	CbGpPWpGaD
Drospirenone—AR—Coregulation of Androgen receptor activity—AKT1—uterine cancer	1.49e-05	0.0021	CbGpPWpGaD
Drospirenone—PGR—Signaling by ERBB4—NRAS—uterine cancer	1.45e-05	0.00206	CbGpPWpGaD
Drospirenone—PGR—Generic Transcription Pathway—CDKN2B—uterine cancer	1.45e-05	0.00205	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	1.44e-05	0.00204	CbGpPWpGaD
Drospirenone—PTGS2—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	1.43e-05	0.00202	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	1.42e-05	0.00202	CbGpPWpGaD
Drospirenone—PTGS2—C-MYB transcription factor network—CDKN2A—uterine cancer	1.41e-05	0.00199	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—ESR2—uterine cancer	1.4e-05	0.00199	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—INHBA—uterine cancer	1.38e-05	0.00196	CbGpPWpGaD
Drospirenone—AR—Generic Transcription Pathway—ESR2—uterine cancer	1.35e-05	0.00192	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—CXCL8—uterine cancer	1.35e-05	0.00192	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	1.35e-05	0.00191	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	1.35e-05	0.00191	CbGpPWpGaD
Drospirenone—PGR—Generic Transcription Pathway—SMAD3—uterine cancer	1.32e-05	0.00187	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—MME—uterine cancer	1.3e-05	0.00184	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—CTNNB1—uterine cancer	1.28e-05	0.00181	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	1.28e-05	0.00181	CbGpPWpGaD
Drospirenone—PGR—Signaling by ERBB4—KRAS—uterine cancer	1.25e-05	0.00177	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—PTEN—uterine cancer	1.25e-05	0.00177	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—CTNNB1—uterine cancer	1.25e-05	0.00177	CbGpPWpGaD
Drospirenone—PTGS2—C-MYB transcription factor network—CDKN1B—uterine cancer	1.25e-05	0.00177	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—AKR1B10—uterine cancer	1.23e-05	0.00175	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—CCL2—uterine cancer	1.23e-05	0.00174	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	1.21e-05	0.00172	CbGpPWpGaD
Drospirenone—PTGS2—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	1.21e-05	0.00172	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—SRD5A2—uterine cancer	1.21e-05	0.00171	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—NDUFB11—uterine cancer	1.21e-05	0.00171	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—EP300—uterine cancer	1.19e-05	0.00169	CbGpPWpGaD
Drospirenone—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—uterine cancer	1.18e-05	0.00168	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.17e-05	0.00166	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—EP300—uterine cancer	1.16e-05	0.00164	CbGpPWpGaD
Drospirenone—PGR—Signaling by ERBB4—PIK3CA—uterine cancer	1.15e-05	0.00163	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—CDKN2B—uterine cancer	1.14e-05	0.00162	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—VEGFA—uterine cancer	1.13e-05	0.0016	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	1.12e-05	0.00159	CbGpPWpGaD
Drospirenone—BCHE—Phospholipid metabolism—PTEN—uterine cancer	1.12e-05	0.00159	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.11e-05	0.00157	CbGpPWpGaD
Drospirenone—AR—Generic Transcription Pathway—CDKN2B—uterine cancer	1.1e-05	0.00156	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—VEGFA—uterine cancer	1.1e-05	0.00156	CbGpPWpGaD
Drospirenone—AR—Androgen receptor signaling pathway—AKT1—uterine cancer	1.1e-05	0.00156	CbGpPWpGaD
Drospirenone—PTGS2—C-MYB transcription factor network—EP300—uterine cancer	1.09e-05	0.00155	CbGpPWpGaD
Drospirenone—PGR—Generic Transcription Pathway—ESR1—uterine cancer	1.08e-05	0.00153	CbGpPWpGaD
Drospirenone—PGR—Signaling by ERBB4—HRAS—uterine cancer	1.06e-05	0.00151	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	1.06e-05	0.0015	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—SMAD3—uterine cancer	1.04e-05	0.00148	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	1.03e-05	0.00147	CbGpPWpGaD
Drospirenone—PTGS2—C-MYB transcription factor network—NRAS—uterine cancer	1.02e-05	0.00145	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—RNF43—uterine cancer	1.02e-05	0.00145	CbGpPWpGaD
Drospirenone—AR—Generic Transcription Pathway—SMAD3—uterine cancer	1.01e-05	0.00143	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	9.91e-06	0.0014	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	9.87e-06	0.0014	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—CXCL8—uterine cancer	9.72e-06	0.00138	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—KRAS—uterine cancer	9.59e-06	0.00136	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	9.5e-06	0.00135	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—CDKN1B—uterine cancer	9.5e-06	0.00135	CbGpPWpGaD
Drospirenone—PGR—Signaling by ERBB4—AKT1—uterine cancer	9.4e-06	0.00133	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—INHBA—uterine cancer	9.35e-06	0.00133	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	9.35e-06	0.00132	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—EZH2—uterine cancer	9.23e-06	0.00131	CbGpPWpGaD
Drospirenone—PTGS2—C-MYB transcription factor network—KRAS—uterine cancer	8.81e-06	0.00125	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—AKR1B1—uterine cancer	8.73e-06	0.00124	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—STAR—uterine cancer	8.73e-06	0.00124	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	8.63e-06	0.00122	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—ESR2—uterine cancer	8.56e-06	0.00121	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—FBXW7—uterine cancer	8.53e-06	0.00121	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—TP53—uterine cancer	8.52e-06	0.00121	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—ESR1—uterine cancer	8.52e-06	0.00121	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—AKR1C1—uterine cancer	8.42e-06	0.00119	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—SRD5A2—uterine cancer	8.31e-06	0.00118	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—NDUFB11—uterine cancer	8.31e-06	0.00118	CbGpPWpGaD
Drospirenone—AR—Generic Transcription Pathway—ESR1—uterine cancer	8.21e-06	0.00116	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	8.08e-06	0.00114	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	7.94e-06	0.00113	CbGpPWpGaD
Drospirenone—BCHE—Phospholipid metabolism—PIK3CA—uterine cancer	7.91e-06	0.00112	CbGpPWpGaD
Drospirenone—PTGS2—Disease—AKR1B10—uterine cancer	7.72e-06	0.00109	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	7.63e-06	0.00108	CbGpPWpGaD
Drospirenone—PTGS2—C-MYB transcription factor network—HRAS—uterine cancer	7.49e-06	0.00106	CbGpPWpGaD
Drospirenone—AR—Gene Expression—PGR—uterine cancer	7.4e-06	0.00105	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	7.3e-06	0.00103	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—AKT1—uterine cancer	7.2e-06	0.00102	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	7.06e-06	0.001	CbGpPWpGaD
Drospirenone—AR—Gene Expression—EZH2—uterine cancer	7.03e-06	0.000996	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	6.98e-06	0.000988	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—CDKN2B—uterine cancer	6.96e-06	0.000987	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—POLD1—uterine cancer	6.85e-06	0.000971	CbGpPWpGaD
Drospirenone—AR—Gene Expression—ESR2—uterine cancer	6.52e-06	0.000923	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—AKR1C3—uterine cancer	6.48e-06	0.000918	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	6.46e-06	0.000915	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—AKR1C1—uterine cancer	6.41e-06	0.000908	CbGpPWpGaD
Drospirenone—PTGS2—Disease—RNF43—uterine cancer	6.4e-06	0.000906	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—SMAD3—uterine cancer	6.36e-06	0.000901	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	6.1e-06	0.000865	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—YWHAE—uterine cancer	6.03e-06	0.000854	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—AKR1B1—uterine cancer	6.01e-06	0.000852	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—STAR—uterine cancer	6.01e-06	0.000852	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—TP53—uterine cancer	5.97e-06	0.000845	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	5.96e-06	0.000845	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	5.95e-06	0.000843	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	5.94e-06	0.000842	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—FBXW7—uterine cancer	5.78e-06	0.000819	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—RRM2—uterine cancer	5.71e-06	0.000809	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	5.67e-06	0.000804	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—DCN—uterine cancer	5.55e-06	0.000786	CbGpPWpGaD
Drospirenone—BCHE—Transmission across Chemical Synapses—HRAS—uterine cancer	5.44e-06	0.00077	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	5.37e-06	0.000761	CbGpPWpGaD
Drospirenone—AR—Gene Expression—CDKN2B—uterine cancer	5.31e-06	0.000752	CbGpPWpGaD
Drospirenone—PTGS2—Disease—AKR1C1—uterine cancer	5.27e-06	0.000746	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CYP11A1—uterine cancer	5.23e-06	0.00074	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—ESR1—uterine cancer	5.19e-06	0.000735	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—STK11—uterine cancer	5.05e-06	0.000716	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—AKR1C3—uterine cancer	4.93e-06	0.000699	CbGpPWpGaD
Drospirenone—AR—Gene Expression—SMAD3—uterine cancer	4.84e-06	0.000686	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—SOCS3—uterine cancer	4.73e-06	0.00067	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—POLD1—uterine cancer	4.72e-06	0.000668	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	4.57e-06	0.000647	CbGpPWpGaD
Drospirenone—PTGS2—Disease—DCN—uterine cancer	4.56e-06	0.000646	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CDKN2B—uterine cancer	4.53e-06	0.000641	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—AKR1C1—uterine cancer	4.41e-06	0.000625	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—IGF1R—uterine cancer	4.4e-06	0.000623	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—CCL2—uterine cancer	4.39e-06	0.000621	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	4.2e-06	0.000594	CbGpPWpGaD
Drospirenone—BCHE—Neuronal System—HRAS—uterine cancer	4.17e-06	0.00059	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—SMAD3—uterine cancer	4.13e-06	0.000586	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	4.06e-06	0.000575	CbGpPWpGaD
Drospirenone—PTGS2—Disease—AKR1C3—uterine cancer	4.06e-06	0.000575	CbGpPWpGaD
Drospirenone—AR—Gene Expression—ESR1—uterine cancer	3.95e-06	0.00056	CbGpPWpGaD
Drospirenone—PTGS2—Disease—HMGA1—uterine cancer	3.95e-06	0.00056	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—FGFR2—uterine cancer	3.94e-06	0.000559	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—RRM2—uterine cancer	3.93e-06	0.000557	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—STK11—uterine cancer	3.84e-06	0.000545	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CYP19A1—uterine cancer	3.84e-06	0.000545	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—DCN—uterine cancer	3.82e-06	0.000541	CbGpPWpGaD
Drospirenone—PTGS2—Disease—FBXW7—uterine cancer	3.62e-06	0.000512	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	3.61e-06	0.000511	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CYP11A1—uterine cancer	3.6e-06	0.00051	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—CXCL8—uterine cancer	3.47e-06	0.000491	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—EP300—uterine cancer	3.44e-06	0.000488	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	3.43e-06	0.000486	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—AKR1C3—uterine cancer	3.4e-06	0.000481	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—ESR1—uterine cancer	3.37e-06	0.000478	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—CTNNB1—uterine cancer	3.2e-06	0.000453	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—AKT1—uterine cancer	3.07e-06	0.000435	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CCL2—uterine cancer	2.97e-06	0.000421	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—MTHFR—uterine cancer	2.89e-06	0.000409	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CDKN2B—uterine cancer	2.83e-06	0.000401	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—STK11—uterine cancer	2.65e-06	0.000375	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CYP19A1—uterine cancer	2.65e-06	0.000375	CbGpPWpGaD
Drospirenone—PTGS2—Disease—SMAD3—uterine cancer	2.59e-06	0.000366	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.55e-06	0.000361	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.48e-06	0.000352	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—ERBB2—uterine cancer	2.48e-06	0.000351	CbGpPWpGaD
Drospirenone—PTGS2—Disease—FGFR2—uterine cancer	2.47e-06	0.000349	CbGpPWpGaD
Drospirenone—PTGS2—Disease—MTHFR—uterine cancer	2.37e-06	0.000336	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.37e-06	0.000336	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CXCL8—uterine cancer	2.35e-06	0.000333	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CDKN1B—uterine cancer	2.29e-06	0.000325	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CTNNB1—uterine cancer	2.17e-06	0.000307	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PTEN—uterine cancer	2.11e-06	0.000299	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—EP300—uterine cancer	2.01e-06	0.000285	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—MTHFR—uterine cancer	1.99e-06	0.000282	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—VEGFA—uterine cancer	1.91e-06	0.00027	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—NRAS—uterine cancer	1.88e-06	0.000267	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—AKT1—uterine cancer	1.87e-06	0.000265	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.75e-06	0.000248	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—KRAS—uterine cancer	1.62e-06	0.00023	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PTEN—uterine cancer	1.61e-06	0.000228	CbGpPWpGaD
Drospirenone—PTGS2—Disease—ERBB2—uterine cancer	1.55e-06	0.000219	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—EP300—uterine cancer	1.53e-06	0.000217	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PIK3CA—uterine cancer	1.49e-06	0.000211	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—TP53—uterine cancer	1.44e-06	0.000204	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CDKN1B—uterine cancer	1.43e-06	0.000203	CbGpPWpGaD
Drospirenone—AR—Gene Expression—AKT1—uterine cancer	1.43e-06	0.000202	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—HRAS—uterine cancer	1.38e-06	0.000195	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CTNNB1—uterine cancer	1.36e-06	0.000192	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PTEN—uterine cancer	1.32e-06	0.000187	CbGpPWpGaD
Drospirenone—PTGS2—Disease—EP300—uterine cancer	1.26e-06	0.000178	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—AKT1—uterine cancer	1.22e-06	0.000172	CbGpPWpGaD
Drospirenone—PTGS2—Disease—NRAS—uterine cancer	1.18e-06	0.000167	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PIK3CA—uterine cancer	1.13e-06	0.000161	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PTEN—uterine cancer	1.11e-06	0.000157	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—EP300—uterine cancer	1.06e-06	0.000149	CbGpPWpGaD
Drospirenone—PTGS2—Disease—KRAS—uterine cancer	1.01e-06	0.000144	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PIK3CA—uterine cancer	9.32e-07	0.000132	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—AKT1—uterine cancer	9.26e-07	0.000131	CbGpPWpGaD
Drospirenone—PTGS2—Disease—HRAS—uterine cancer	8.62e-07	0.000122	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PIK3CA—uterine cancer	7.8e-07	0.000111	CbGpPWpGaD
Drospirenone—PTGS2—Disease—AKT1—uterine cancer	7.61e-07	0.000108	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—AKT1—uterine cancer	6.38e-07	9.03e-05	CbGpPWpGaD
